TrialX

1 review

TrialX iConnect is an enterprise-grade patient recruitment management system designed to streamline and enhance the clinical trial recruitment process for academic medical centers, pharmaceutical sponsors, and patient advocacy groups. By centralizing and standardizing recruitment initiatives, iConnect facilitates efficient patient engagement, improves trial visibility, and optimizes recruitment workflows. Key Features and Functionality: - Clinical Trials Finder: Provides an intuitive interface for participants to search and locate relevant clinical trials nearby, with configurable search and filtering capabilities. - Pre-screeners: Enables the creation of customizable questionnaires with various question types and branching logic to support diverse recruitment flows. - Study Website Builder: Allows for the development of branded, multilingual study websites using drag-and-drop content blocks, eliminating the need for coding. - Referral Enrollment Tracking: Monitors study metrics and recruitment efforts by tracking referrals, sources, and patient enrollment across the enterprise. - Volunteer Registry: Builds a searchable database of potential participants and facilitates targeted communications to engage them effectively. - Real-time Analytics: Offers pre-built and customizable dashboards to provide real-time insights at both the study and enterprise levels, with options for alerts and scheduled reports. Primary Value and Problem Solved: iConnect addresses the critical challenge of patient recruitment in clinical trials by providing a comprehensive platform that enhances trial visibility, simplifies participant engagement, and streamlines recruitment workflows. By integrating advanced features such as real-time analytics, customizable pre-screeners, and multilingual study websites, iConnect empowers research organizations to efficiently manage recruitment processes, improve participant diversity, and achieve enrollment targets more effectively. This leads to accelerated trial timelines, reduced costs, and ultimately, the advancement of medical research and patient care.